93 related articles for article (PubMed ID: 17943579)
1. Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the goal study.
Bateman ED; Clark TJ; Frith L; Bousquet J; Busse WW; Pedersen SE;
J Asthma; 2007 Oct; 44(8):667-73. PubMed ID: 17943579
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
3. Components of asthma control and treatment response of individual control criteria in children: analysis of the PEACE study.
Pedersen S; Maspero J; Gul N; Sharma R
Pediatr Pulmonol; 2011 Dec; 46(12):1182-8. PubMed ID: 21751432
[TBL] [Abstract][Full Text] [Related]
4. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
[TBL] [Abstract][Full Text] [Related]
5. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
6. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
Miyagawa T
Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
[TBL] [Abstract][Full Text] [Related]
7. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[TBL] [Abstract][Full Text] [Related]
8. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
Adachi M; Aizawa H; Ishihara K; Ohta K; Sano Y; Taniguchi H; Nakashima M
Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875
[TBL] [Abstract][Full Text] [Related]
9. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study.
Pedersen SE; Bateman ED; Bousquet J; Busse WW; Yoxall S; Clark TJ;
J Allergy Clin Immunol; 2007 Nov; 120(5):1036-42. PubMed ID: 17935765
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
11. Asthma control over 3 years in a real-life study.
Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; James M
Respir Med; 2009 Mar; 103(3):348-55. PubMed ID: 19042115
[TBL] [Abstract][Full Text] [Related]
12. Clinical dose-response relationship of fluticasone propionate in adults with asthma.
Masoli M; Weatherall M; Holt S; Beasley R
Thorax; 2004 Jan; 59(1):16-20. PubMed ID: 14694240
[TBL] [Abstract][Full Text] [Related]
13. [Is guideline-defined asthma control achievable?--secondary publication. The Gaining Optimal Asthma ControL (GOAL) Study].
Pedersen SE
Ugeskr Laeger; 2005 Sep; 167(38):3595-7. PubMed ID: 16219190
[TBL] [Abstract][Full Text] [Related]
14. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
Koenig SM; Ostrom N; Pearlman D; Waitkus-Edwards K; Yancey S; Prillaman BA; Dorinsky P
J Asthma; 2008 Oct; 45(8):681-7. PubMed ID: 18951261
[TBL] [Abstract][Full Text] [Related]
15. The correlation between asthma control and health status: the GOAL study.
Bateman ED; Bousquet J; Keech ML; Busse WW; Clark TJ; Pedersen SE
Eur Respir J; 2007 Jan; 29(1):56-62. PubMed ID: 17050557
[TBL] [Abstract][Full Text] [Related]
16. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
Boulet LP; Franssen E
Respir Med; 2007 Nov; 101(11):2240-7. PubMed ID: 17686624
[TBL] [Abstract][Full Text] [Related]
17. Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma.
van Aalderen WM; Price D; De Baets FM; Price J
Respir Med; 2007 Jul; 101(7):1585-93. PubMed ID: 17254760
[TBL] [Abstract][Full Text] [Related]
18. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
Zetterström O; Dahl R; Lindqvist A; Olsson P
Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes among omalizumab and salmeterol/fluticasone combination therapy patients.
Miller DP; Tom G; Rasouliyan L; Chipps B
J Asthma; 2009 Mar; 46(2):179-85. PubMed ID: 19253127
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma.
Pearlman D; Qaqundah P; Matz J; Yancey SW; Stempel DA; Ortega HG
Pediatr Pulmonol; 2009 May; 44(5):429-35. PubMed ID: 19382218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
